NO307366B1 - Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten - Google Patents

Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten

Info

Publication number
NO307366B1
NO307366B1 NO962547A NO962547A NO307366B1 NO 307366 B1 NO307366 B1 NO 307366B1 NO 962547 A NO962547 A NO 962547A NO 962547 A NO962547 A NO 962547A NO 307366 B1 NO307366 B1 NO 307366B1
Authority
NO
Norway
Prior art keywords
preparation
tablets containing
tablet formulation
formulation prepared
containing paroxetine
Prior art date
Application number
NO962547A
Other languages
English (en)
Norwegian (no)
Other versions
NO962547L (no
NO962547D0 (no
Inventor
Ram Dutta Pathak
David George Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO307366(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO962547L publication Critical patent/NO962547L/no
Publication of NO962547D0 publication Critical patent/NO962547D0/no
Publication of NO307366B1 publication Critical patent/NO307366B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO962547A 1993-12-15 1996-06-14 Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten NO307366B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation
PCT/EP1994/004164 WO1995016448A1 (en) 1993-12-15 1994-12-14 Paroxetine tablets and process to prepare them

Publications (3)

Publication Number Publication Date
NO962547L NO962547L (no) 1996-06-14
NO962547D0 NO962547D0 (no) 1996-06-14
NO307366B1 true NO307366B1 (no) 2000-03-27

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
NO962547A NO307366B1 (no) 1993-12-15 1996-06-14 Fremgangsmåte for fremstilling av tabletter inneholdende paroxetin og tablettformulering fremstilt ved fremgangsmåten

Country Status (35)

Country Link
US (1) US6113944A (de)
EP (1) EP0734260B2 (de)
JP (1) JP3037757B2 (de)
KR (1) KR100367796B1 (de)
CN (1) CN1071116C (de)
AP (1) AP540A (de)
AT (1) ATE180973T1 (de)
AU (1) AU697982B2 (de)
BG (1) BG62755B1 (de)
BR (1) BR9408219A (de)
CA (4) CA2274387A1 (de)
CZ (1) CZ287891B6 (de)
DE (1) DE69419033T2 (de)
DK (1) DK0734260T4 (de)
DZ (1) DZ1835A1 (de)
ES (1) ES2132610T5 (de)
FI (1) FI962445A0 (de)
GB (1) GB9325644D0 (de)
GR (1) GR3031047T3 (de)
HU (1) HUT75880A (de)
IL (1) IL111978A (de)
MA (1) MA23395A1 (de)
MY (1) MY112123A (de)
NO (1) NO307366B1 (de)
NZ (1) NZ277790A (de)
OA (1) OA10297A (de)
PL (1) PL314980A1 (de)
RO (1) RO115413B1 (de)
RU (1) RU2146141C1 (de)
SA (1) SA94150373B1 (de)
SI (1) SI0734260T2 (de)
SK (1) SK282620B6 (de)
UA (1) UA42745C2 (de)
WO (1) WO1995016448A1 (de)
ZA (1) ZA949900B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
EE03970B1 (et) 1997-06-10 2003-02-17 Synthon B.V. 4-fenüülpiperidiinühend, selle valmistamine ja kasutamine ning seda sisaldav ravim
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
EP1313474A2 (de) * 2000-08-28 2003-05-28 Synthon B.V. Paroxetin-zusammensetzungen und verfahren zu deren herstellung
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
HRP20031073A2 (en) 2001-07-31 2004-04-30 Lundbeck & Co As H Crystalline composition containing escitalopram
WO2003044012A1 (en) * 2001-10-22 2003-05-30 Synthon B.V. N-formyl derivatives of paroxetine
US7396542B2 (en) * 2001-12-28 2008-07-08 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
CN1997374A (zh) * 2004-06-23 2007-07-11 默克公司 雌激素受体调节剂
US20060063737A1 (en) * 2004-08-18 2006-03-23 Holmdahl Lisa K Liquid paroxetine compositions
US20060039975A1 (en) * 2004-08-20 2006-02-23 Zalman Vilkov Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
WO2007058998A2 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (de) * 1974-03-04 1975-09-11
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
DE3680184D1 (de) * 1985-08-10 1991-08-14 Beecham Group Plc Verfahren zur herstellung von arylpiperidincarbinol.
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223403B1 (de) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
JPH06502854A (ja) * 1990-11-24 1994-03-31 ビーチャム・グループ・パブリック・リミテッド・カンパニー 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
FI962445L (fi) 1996-06-12
SA94150373B1 (ar) 2006-05-27
CZ176396A3 (en) 1996-09-11
CN1071116C (zh) 2001-09-19
ATE180973T1 (de) 1999-06-15
CA2178637C (en) 1997-12-23
DK0734260T4 (da) 2008-09-29
WO1995016448A1 (en) 1995-06-22
MY112123A (en) 2001-04-30
BG62755B1 (bg) 2000-07-31
PL314980A1 (en) 1996-09-30
BR9408219A (pt) 1997-08-26
CZ287891B6 (cs) 2001-03-14
DZ1835A1 (fr) 2002-02-17
DE69419033D1 (de) 1999-07-15
JPH09506602A (ja) 1997-06-30
KR100367796B1 (ko) 2003-07-22
MA23395A1 (fr) 1995-07-01
EP0734260B1 (de) 1999-06-09
NO962547L (no) 1996-06-14
CA2274389A1 (en) 1995-06-22
AU697982B2 (en) 1998-10-22
ES2132610T3 (es) 1999-08-16
CA2214575A1 (en) 1995-06-22
EP0734260B2 (de) 2008-07-09
GB9325644D0 (en) 1994-02-16
NO962547D0 (no) 1996-06-14
CA2214575C (en) 1999-12-07
CN1137236A (zh) 1996-12-04
CA2274389C (en) 2004-09-14
UA42745C2 (uk) 2001-11-15
CA2178637A1 (en) 1995-06-22
NZ277790A (en) 1998-02-26
CA2274387A1 (en) 1995-06-22
BG100648A (bg) 1997-02-28
EP0734260A1 (de) 1996-10-02
FI962445A7 (fi) 1996-06-12
SI0734260T2 (sl) 2008-12-31
ZA949900B (en) 1995-10-10
RO115413B1 (ro) 2000-02-28
FI962445A0 (fi) 1996-06-12
HU9601665D0 (en) 1996-08-28
IL111978A0 (en) 1995-03-15
DK0734260T3 (da) 1999-11-15
HK1012285A1 (en) 1999-07-30
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
SI0734260T1 (sl) 1999-08-31
AP540A (en) 1996-09-20
RU2146141C1 (ru) 2000-03-10
JP3037757B2 (ja) 2000-05-08
AP9400704A0 (en) 1995-01-31
SA94150373A (ar) 2005-12-03
IL111978A (en) 2000-07-16
DE69419033T2 (de) 1999-11-25
HUT75880A (en) 1997-05-28
US6113944A (en) 2000-09-05
ES2132610T5 (es) 2008-12-16
SK282620B6 (sk) 2002-10-08
GR3031047T3 (en) 1999-12-31
AU1314595A (en) 1995-07-03

Similar Documents

Publication Publication Date Title
DK0734260T3 (da) Paroxetintabletter og fremgangsmåde til fremstilling deraf
NO973479L (no) Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
PL299176A1 (en) Novel heterocyclic compounds, pharmaceutical agent, method of obtaining such novel heterocyclic compounds and initial compounds for obtaining them
FI940585A7 (fi) Pinnoittamattomat tabletit ja menetelmä niiden valmistamiseksi
DK0622408T3 (da) Sammensætning og fremgangsmåde til fremstilling af gelatinfrie, bløde kapsler
DK0477049T3 (da) 3-amido-pyrazolderivater, fremgangsmåde til deres fremstilling og farmaceutiske præparater indeholdende dem
HUT72639A (en) Substituted thiazolidinedione derivatives, pharmaceutical compositions containing them and process for their preparation
IS3693A7 (is) Aðferð til framleiðslu þríglýserið og samsetningar þríglýserið efnablöndu
NO975987D0 (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
HUT64366A (en) Process for producing hiv-protease inhibitor compounds and pharmaceutical preparatives containing them
PL305288A1 (en) Novel piperidine derivatives, method of obtaining them and pharmaceutical agent
HUT59389A (en) Process for producing heterocyclic compounds and pharmaceutical compositions comprising same
HUT54139A (en) Process for producing n-heteroaryl-4-quinolineamine derivatives and pharmaceutical compositions comprising such compounds
PL301281A1 (en) Novel organic compounds, method of obtaining such novel compounds and pharmaceutical composition containing them
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
HUT54695A (en) Process for producing new acetylcholinesteraze inhibitors and pharmaceutical compositions containing them
GB2304714B (en) New piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
HU9402187D0 (en) Heterocyclic compounds, process for producing them and pharmaceutical compositions containing them
NO306717B1 (no) Fremgangsmåte for fremstilling av piperidin-karbinoler
HUT54378A (en) Process for producing squalene-synthetaze inhibitors containing phosphours and pharmaceutical compositions containing them
HUT54146A (en) Process for producing new benzodioxole derivatives and pharmaceutical compositions comprising such compounds
HUT56373A (en) Process for producing pyranobenzoxadiazole derivatives and pharmaceutical compositions comprising such compounds
HUT48210A (en) Process for producing new tetrahydropyridine derivatives and pharmaceutical compositions comprising such compounds
NO308004B1 (no) Nye aminofenylfosfonsyreforbindelser og farmasøytiske sammensetninger inneholdende dem
DK0806949T3 (da) Ny farmaceutisk komposition, der indeholder trimebutin, og fremgangsmåde til fremstilling deraf

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees